Patient-reported outcomes of a randomized phase III clinical trial of adjuvant radiation versus chemoradiation in intermediate risk, stage I/IIA cervical cancer patients treated with initial radical hysterectomy and pelvic lymphadenectomy (NRG/GOG-0263). - Chase DM; Huang HQ; Deng W; Koh WJ; Rodgers W; Small W Jr; Albuquerque K; Mayadev J; Leath CA; Monk B; Kim BJ; Kim DY; et al. (Gynecologic oncology, 2025)